يعرض 1 - 20 نتائج من 51 نتيجة بحث عن '"Dimier, N"', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    Relation: pii: 483243; Broeske, A. -M. E., Korfi, K., Belousov, A., Wilson, S., Ooi, C. -H., Bolen, C. R., Canamero, M., Alcaide, E. G., James, I., Piccione, E. C., Carlile, D. J., Dimier, N., Umana, P., Bacac, M., Weisser, M. & Dickinson, M. (2022). Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma. BLOOD ADVANCES, 6 (3), pp.1025-1037. https://doi.org/10.1182/bloodadvances.2021005954.; http://hdl.handle.net/11343/307779

  4. 4
    Academic Journal
  5. 5
    Academic Journal

    Relation: Hutchings, M., Morschhauser, F., Iacoboni, G., Carlo-Stella, C., Offner, F. C., Sureda, A., Salles, G., Martinez-Lopez, J., Crump, M., Thomas, D. N., Morcos, P. N., Ferlini, C., Broeske, A. -M. E., Belousov, A., Bacac, M., Dimier, N., Carlile, D. J., Lundberg, L., Perez-Callejo, D. ,. Dickinson, M. J. (2021). Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial. JOURNAL OF CLINICAL ONCOLOGY, 39 (18), pp.1959-+. https://doi.org/10.1200/JCO.20.03175.; http://hdl.handle.net/11343/288764

  6. 6
    Academic Journal

    المساهمون: Université de Lille, CHU Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365

    وصف الملف: application/octet-stream

    Relation: British Journal of Haematology; BJMH; http://hdl.handle.net/20.500.12210/82424

  7. 7
    Academic Journal

    المساهمون: Université de Lille, CHU Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365

    وصف الملف: application/octet-stream

    Relation: Clinical Lymphoma & Myeloma & Leukemia; Clin Lymphoma Myeloma Leuk; http://hdl.handle.net/20.500.12210/82398

  8. 8
    Academic Journal
  9. 9
  10. 10
    Academic Journal

    المساهمون: Dixon, J. G., Dimier, N., Nielsen, T., Zheng, J., Marcus, R., Morschhauser, F., Evens, A. M., Federico, M., Blum, K. A., Shi, Q.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/35491747; info:eu-repo/semantics/altIdentifier/wos/WOS:000789213900001; volume:198; issue:2; firstpage:333; lastpage:337; journal:BRITISH JOURNAL OF HAEMATOLOGY; http://hdl.handle.net/11380/1289371; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85129209810

  11. 11
    Academic Journal

    المصدر: Dimier , N , Delmar , P , Ward , C , Morariu-Zamfir , R , Fingerle-Rowson , G , Bahlo , J , Fischer , K , Eichhorst , B , Goede , V , Dongen , J , Ritgen , M , Bottcher , S , Langerak , T , Kneba , M & Hallek , M 2018 , ' A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL ' , Blood , vol. 131 , no. 9 , pp. 955-962 . https://doi.org/10.1182/blood-2017-06-792333

    وصف الملف: application/pdf

  12. 12
    Academic Journal
  13. 13
    Academic Journal

    المساهمون: Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)

    المصدر: ISSN: 2152-2669 ; Clinical Lymphoma & Myeloma & Leukemia ; https://hal.univ-lille.fr/hal-04212003 ; Clinical Lymphoma & Myeloma & Leukemia, 2022, Clinical Lymphoma & Myeloma & Leukemia, 22 (11), pp.e1009-e1018. ⟨10.1016/j.clml.2022.07.015⟩.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    Relation: info:eu-repo/semantics/altIdentifier/pmid/36045021; hal-04212003; https://hal.univ-lille.fr/hal-04212003; PUBMED: 36045021

  14. 14
    Academic Journal

    المساهمون: Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)

    المصدر: ISSN: 0732-183X.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    Relation: info:eu-repo/semantics/altIdentifier/pmid/33739857; hal-04197279; https://hal.univ-lille.fr/hal-04197279; PUBMED: 33739857

  15. 15
  16. 16
    Academic Journal

    المصدر: Sehn , L H , Chua , N , Mayer , J , Dueck , G , Trneny , M , Bouabdallah , K , Fowler , N , Delwail , V , Press , O , Salles , G , Gribben , J , Lennard , A , Lugtenburg , E , Dimier , N , Wassner-Fritsch , E , Fingerle-Rowson , G & Cheson , BD 2016 , ' Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial ' , Lancet Oncology , vol. ....

  17. 17
  18. 18
    Conference
  19. 19
    Conference
  20. 20
    Dissertation/ Thesis